SEC Form 4 · accession 0001209191-15-079993
Xylem Inc. · XYL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Markos I Tambakeras
Director
Period of report
Nov 12, 2015
Accepted (ET)
Nov 13, 2015 · 2:37 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001524472
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 12, 2015 | M | 3,970 | $18.633 | A | 38,169 | D | |
| Common StockF1 | Nov 12, 2015 | S | 2,025 | $36.7262 | D | 36,144 | D | |
| Common Stock | holding | — | — | — | 17,974 | I | By Tambakeras Family Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $18.633 | Nov 12, 2015 | M | 3,970 | D | — | Mar 5, 2016 | Common Stock | 3,970 | 0 | D |
Explanation of responses
- F1This price represents the approximate weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"), of sales that were executed at prices ranging from $36.73 to $36.7253 per Share. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.
- F2These options are fully vested and exercisable.